Key result
Intratracheal delivery of donor splenocytes or Kb peptide with CD40 pathway blockade induced indefinite survival (>200 days) of fully allogeneic cardiac grafts in mice compared to 7 days in controls.
Why the study?
Does intratracheal delivery of alloantigens combined with CD40 pathway blockade improve allogeneic cardiac graft survival in mice?
Does intratracheal delivery of alloantigens combined with CD40 pathway blockade improve allogeneic cardiac graft survival in mice?
Intratracheal delivery of alloantigens combined with CD40 pathway blockade induces operational tolerance and indefinite survival of fully allogeneic cardiac grafts in a mouse model.
Answers are grounded in this paper and cite their sources.
Hypothesis-generating for tolerance induction in cardiac allografts; leaves open translation beyond this murine model.
BACKGROUND: The authors previously showed that intratracheal delivery (ITD) of donor splenocytes induced prolonged survival of fully allogeneic cardiac grafts in mice. In this study, this treatment protocol was combined with blockade of the CD40 pathway in an attempt to induce operational tolerance. METHODS: CBA mice were given donor splenocytes (1x107) or Kb peptide (100 microg) by ITD with or without antibody specific for mouse CD40 ligand (MR1, 200 microg) 7 days before transplantation of a C57BL/10 heart. Also, splenocyte (5 x 107) from primary recipient CBA mice given ITD of donor splenocytes or Kb peptide plus MR1 were adoptively transferred into naive CBA secondary recipients 7 days after the pretreatment and C57BL/10 hearts were transplanted into those recipients the same day. RESULTS: ITD of donor splenocytes and Kb peptide induced prolonged survival of cardiac grafts (median survival time [MST], 74 and 56 days, respectively), whereas naive control mice and mice pretreated with syngeneic splenocytes had acute graft rejection (MST in both groups, 7 days). When MR1 was included, all grafts survived indefinitely (>200 days), but mice pretreated with MR1 alone had graft rejection (MST, 54 days). Mice bearing cardiac grafts had acceptance of skin grafts from C57BL/10 but not BALB/c mice, demonstrating that operational tolerance was induced. Secondary recipients given adoptive transfer of splenocytes from primary recipients of the combined treatment had acceptance of C57BL/10 grafts, suggesting that regulatory cells were generated within 7 days of pretreatment. CONCLUSIONS: ITD of donor splenocytes or Kb peptide under blockade of the CD40 pathway induced operational tolerance and generated regulatory cells.
No takes yet. Share an insight, caveat, or question.
Uchida et al. (2003) studied Allogeneic cardiac graft rejection. Intratracheal delivery of donor splenocytes or Kb peptide with MR1 vs. Naive control mice, syngeneic splenocytes, or MR1 alone was evaluated on Median survival time of cardiac grafts. Intratracheal delivery of donor splenocytes or Kb peptide with CD40 pathway blockade induced indefinite survival (>200 days) of fully allogeneic cardiac grafts in mice compared to 7 days in controls.
Synapse has enriched 10 related papers. Consider them for comparative context: